Top Tweets for #GyncSM

about 19 hours ago

2/2 "After hearing about your cancer, what was the most offensive thing someone said or did without realizing it?" Oh that was a big one for me- after I told my Aunt's PCP I was in treatment for OC she told me - Oh that's a bad one. " Really ????? #gyncsm

0

1

0

12

David Scott Miller @dsmgyo

about 19 hours ago

Uncensored, Out Loud: 6 Women. 10 Gyn Cancer Questions. | Ep. 1 Stigma https://t.co/AwphRIjGlI via @YouTube Amazing insights into experiences of gyn cancer survivors? Sharing your gyn cancer with others is tough and there is stigma. Thank you @IGCSociety #gyncsm 1/2

1

3

0

215

eMedEvents

@eMedEvents

about 21 hours ago

Breast & gynecologic cancer treatment is evolving faster than most CMEs can keep up. Stay ahead of the curve with #HerHealth2026. 📍 New York City | 🗓️ October 9–10, 2026 👉 Register now: https://t.co/ckeEXfMaLr #MedTwitter #gyncsm #gynonc #GynecologicalOncology #BreastCancer #OvarianCancer #OncTwitter #GynecologicCancerAwarenessMonth #eMedEvents

eMedEvents's tweet photo. Breast & gynecologic cancer treatment is evolving faster than most CMEs can keep up. Stay ahead of the curve with #HerHealth2026.

📍 New York City | 🗓️ October 9–10, 2026

👉 Register now: https://t.co/ckeEXfMaLr

#MedTwitter #gyncsm #gynonc #GynecologicalOncology #BreastCancer #OvarianCancer #OncTwitter #GynecologicCancerAwarenessMonth #eMedEvents

0

119

6 days ago · Dallas

Now open at @utswcancer, @parklandhealth, and an @NRGonc institution near you: trial #GY036! Check out the podcast. #gyncsm #ovariancancer #clinicaltrial #parp #olaparib #GynecologicCancerAwarenessMonth @LYNPARZAhcp

NRG Oncology @NRGonc

7 days ago

This year for #OvarianCancerAwarenessMonth we interview Dr. Ying Liu regarding the NRG-GY036 for ovarian, fallopian tube, and peritoneal cancers. Listen on Apple Podcasts, Spotify, YouTube, Amazon, and stream directly from https://t.co/8pQCxda9B0. #GynecologicCancerAwarenessMonth

NRGonc's tweet photo. This year for #OvarianCancerAwarenessMonth we interview Dr. Ying Liu regarding the NRG-GY036 for ovarian, fallopian tube, and peritoneal cancers. Listen on Apple Podcasts, Spotify, YouTube, Amazon, and stream directly from https://t.co/8pQCxda9B0. #GynecologicCancerAwarenessMonth https://t.co/MYYoOqYgUG

0

4

2

0

1K

0

3

1

0

210

CancerNetwork®

@CancerNetwrk

7 days ago

Rezatapopt monotherapy elicited an ORR of 46% in platinum-resistant/refractory ovarian cancer harboring a TP53 Y220C mutation in the phase 2 PYNNACLE trial. https://t.co/GZSB9Td1KV #gyncsm #ovariancancer #oncology

0

2

1

0

472

Mike Thompson, MD, PhD, FASCO

@mtmdphd

9 days ago

Organizing Online Health Content: Developing Hashtag Collections for Healthier Internet-Based People and Communities [Jun 28, 2019] @subatomicdoc et al. @JCOCCI_ASCO https://t.co/EMbz4XBZqT #ayacsm #bcsm #btsm #gyncsm #lcsm #mmsm #pancsm

mtmdphd's tweet photo. Organizing Online Health Content: Developing Hashtag Collections for Healthier Internet-Based People and Communities [Jun 28, 2019] @subatomicdoc et al. @JCOCCI_ASCO https://t.co/EMbz4XBZqT #ayacsm #bcsm #btsm #gyncsm #lcsm #mmsm #pancsm https://t.co/lRPaLwAMRq

0

3

2

0

487

Marie Ennis-O'Connor @JBBC

10 days ago

Thanks @JBBC for sharing my blog post and helping spread awareness of ovarian cancer. #gyncsm

12 days ago

The weekly blog round up featuring @womenofteal @amjohnston1315 @yvonnewatterson @letlifehappen @bethlgainer @gabbymot https://t.co/V1ZUmX1n9Q

JBBC's tweet photo. The weekly blog round up featuring @womenofteal @amjohnston1315 @yvonnewatterson @letlifehappen @bethlgainer @gabbymot https://t.co/V1ZUmX1n9Q https://t.co/lLGfcdGP4s

0

5

3

2

529

0

3

0

254

Journal of Clinical Oncology

10 days ago

Full article: “Integrating Patients’ Perspectives into Continuing Medical Education (CME) to Address Disparities in Gynecologic Cancer Care” https://t.co/d9NzOAuOih #gyncsm 3 yrs of CME data with patient narratives included increased provider intention to modify practice

0

3

0

193

@JCO_ASCO

11 days ago

Systemic Treatment of Ovarian Cancer Recurrence: ASCO Living Guideline, Version 2026.1.0. Co-authored by @IslandJewelsena. Read the full article. https://t.co/HakOT4v7QQ #OvarianCancer #gyncsm

0

4

2

5

2K

FdtnForWomensCancer @GYNCancer

17 days ago

No one should face a gynecologic cancer journey alone. 💜 Join the Foundation for Women’s Cancer Patient & Advocate Education Forum on Sept. 19 in Washington, DC. Free event for patients, survivors, caregivers & advocates. Register: https://t.co/4IJ1QfVmbL #gyncsm

GYNCancer's tweet photo. No one should face a gynecologic cancer journey alone. 💜 Join the Foundation for Women’s Cancer Patient & Advocate Education Forum on Sept. 19 in Washington, DC. Free event for patients, survivors, caregivers & advocates. Register: https://t.co/4IJ1QfVmbL #gyncsm https://t.co/FzEDExgHNG

0

5

1

0

258

ACS Journal Cancer @JournalCancer

18 days ago

New in Cancer 📗 How can we reduce gynecologic cancer–related deaths in low- and middle-income countries? Review offers insights on evidence-based strategies: https://t.co/xOl8cCVQ3b @OncoAlert @WileyHealth #gyncsm

JournalCancer's tweet photo. New in Cancer 📗 How can we reduce gynecologic cancer–related deaths in low- and middle-income countries?

Review offers insights on evidence-based strategies: https://t.co/xOl8cCVQ3b

@OncoAlert @WileyHealth #gyncsm https://t.co/L06mjOElLN

2

5

6

2

1K

22 days ago

How New Science is Reshaping Ovarian Cancer Treatment and Care @AACR https://t.co/zZI32cMkv3 Excellent overview of the science of treating OC from PARP to ADC's to Immunotherapy #gyncsm

1

5

0

197

22 days ago

ASCO Gynecological Cancers- Ideal Timing for Surgical Cytoreduction in Advanced Ovarian Cancer Goals should be treatment at dedicated high-volume centers, with infrastructure to care for these complex patients https://t.co/6JAchy6CIY #gyncsm

0

4

2

0

185

Mike Thompson, MD, PhD, FASCO

22 days ago

📰Cures? New ADCs? Negative trials? Uncover everything from @ASCO 2026 in gynecologic cancer here ➡️: https://t.co/UgmLZnD1ry #gyncsm #ovca #oncology

0

4

0

929

@mtmdphd

22 days ago

The Needs of Women Treated for Ovarian Cancer: Results From a #gyncsm Twitter Chat [4/26/18] @TLHagan @Nauthshelley @btrfly12 @mtmdphd @DrAttai @subatomicdoc @davidgrahammd @womenofteal @btrfly12 @audvin @drdonsdizon @JPCRR https://t.co/sObUnG51eE

mtmdphd's tweet photo. The Needs of Women Treated for Ovarian Cancer: Results From a #gyncsm Twitter Chat [4/26/18] @TLHagan @Nauthshelley @btrfly12 @mtmdphd @DrAttai @subatomicdoc @davidgrahammd @womenofteal @btrfly12 @audvin @drdonsdizon @JPCRR https://t.co/sObUnG51eE https://t.co/U1ejaRAmqz

0

3

1

0

297

23 days ago

#gyncsm

IJGC

@IJGConline

24 days ago

Impact of NACT on HRD test results in patients with advanced high-grade serous #ovariancancer 🧬 https://t.co/4pr3kIfvLD @pedroramirezMD @RParejaGineOnco @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @ElePanizzolo @esragbilir @ChiaraAinio @alicezampolini @Chiara_4997 @Lawalqdus @kamillaldavid @Dra_AnaConde

IJGConline's tweet photo. Impact of NACT on HRD test results in patients with advanced high-grade serous #ovariancancer

🧬 https://t.co/4pr3kIfvLD

@pedroramirezMD @RParejaGineOnco @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @ElePanizzolo @esragbilir @ChiaraAinio @alicezampolini @Chiara_4997 @Lawalqdus @kamillaldavid @Dra_AnaConde

0

21

11

3

2K

0

3

0

168

25 days ago

�� A nearly 50% reduction in risk of progression: OSE2101 plus pembrolizumab beat best supportive care as maintenance in platinum-sensitive ovarian cancer (HR, 0.53; P < .001). Alexandra Leary, MD, PhD, of @GustaveRoussy, breaks down the TEDOVA data 👇 #ovca #gyncsm https://t.co/ZrLPYM5MTL

0

7

0

2

2K

25 days ago

Sapanisertib and serabelisib plus paclitaxel received @FDA fast track designation for pretreated advanced PI3K/AKT/mTOR pathway–altered endometrial cancer. #gyncsm #oncology https://t.co/L2E25LIocx

0

3

0

1K